This website uses cookies. By continuing you are agreeing to our privacy policy.

Clinical Trials

Sarilumab in Patients With Glucocorticoid-Dependent Sarcoidosis

Institution:

Stanford University

Type:

Individual Site

Purpose:

The purpose of this study is to compare the effectiveness and the safety of sarilumab in patients with glucocorticoid-dependent sarcoidosis. To demonstrate that sarilumab treatment will be effective for inducing and maintaining glucocorticoid-free remission in male or female patients with biopsy proven active, glucocorticoid-dependent sarcoidosis affecting the lungs, lymph nodes, liver, kidneys, spleen, bone, soft tissues, skin, and/or eyes.

Dates:

September 5, 2019 - July 1, 2025

Disease:

Pulmonary Fibrosis

Register:

https://clinicaltrials.gov/ct2/show/NCT04008069?term=sarilumab&cond=Sarcoidosis&rank=1

Contact:

Matthew Baker
541-760-8182
[email protected]

Red button with telephone
Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
Red button of two hand prints
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.

Button of turquoise LUNG FORCE swirl
What is LUNG FORCE?

LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.